About Stem Cell Technologies
Stem Cell Technologies is a company based in Vancouver (Canada) founded in 1993.. Stem Cell Technologies has raised $11.92 million across 9 funding rounds from investors including National Research Council Canada, European Union and BDC. Stem Cell Technologies has completed 3 acquisitions, including Cellular Highways, Propagenix and SQZBiotech. Stem Cell Technologies offers products and services including Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media. Stem Cell Technologies operates in a competitive market with competitors including Abcam, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.92 M (USD)
in 9 rounds
-
Latest Funding Round
$1.14 M (USD), Grant
Apr 01, 2021
-
Investors
National Research Council Canada
& 2 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cellular Highways
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stem Cell Technologies
Stem Cell Technologies offers a comprehensive portfolio of products and services, including Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for detecting proteins in cell research applications
Media for growing and maintaining cells in laboratory settings
Kits for isolating specific cell types from samples
Solutions for cryopreserving cells effectively
Unlock access to complete
Software Development Team
16 people
Senior Team
14 people
Finance and Accounting
13 people
Data Analysis and Operations Team
11 people
Product Management Team
7 people
Leadership Team
6 people
Sales and Marketing
4 people
Business Team
3 people
Unlock access to complete
Funding Insights of Stem Cell Technologies
Stem Cell Technologies has successfully raised a total of $11.92M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $1.14 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $1.1M
-
First Round
First Round
(12 Nov 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Grant - Stem Cell Technologies | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - Stem Cell Technologies | Valuation |
investors |
|
| Nov, 2019 | Amount | Grant - Stem Cell Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stem Cell Technologies
Stem Cell Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada, European Union and BDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Commercial banking services for small and medium-sized enterprises are provided.
|
Founded Year | Domain | Location | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stem Cell Technologies
Stem Cell Technologies has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cellular Highways, Propagenix and SQZBiotech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microfluidic cell sorters are developed for research, diagnostics, and therapeutics.
|
2016 | ||||
|
Cell models and therapies are developed using Conditional Replication technology.
|
2014 | ||||
|
Cell therapies are developed using proprietary Cell Squeeze technology.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Stem Cell Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stem Cell Technologies Comparisons
Competitors of Stem Cell Technologies
Stem Cell Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
|
| domain | founded_year | HQ Location |
Bioreagents and assay kits are developed, with preclinical services provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stem Cell Technologies
Frequently Asked Questions about Stem Cell Technologies
When was Stem Cell Technologies founded?
Stem Cell Technologies was founded in 1993 and raised its 1st funding round 20 years after it was founded.
Where is Stem Cell Technologies located?
Stem Cell Technologies is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is Stem Cell Technologies a funded company?
Stem Cell Technologies is a funded company, having raised a total of $11.92M across 9 funding rounds to date. The company's 1st funding round was a Grant of $16.96K, raised on Nov 12, 2013.
What does Stem Cell Technologies do?
Stem Cell Technologies was founded in 1993 in Vancouver, Canada, within the life sciences sector. Cell culture media and ancillary reagents are produced to support research activities. Products designed for cell isolation, culturing, and assaying are offered, complemented by services and training programs. Operations focus on aiding scientists through these resources in a research-oriented environment.
Who are the top competitors of Stem Cell Technologies?
Stem Cell Technologies's top competitors include Abcam, Meridian Bioscience and BBI Solutions.
What products or services does Stem Cell Technologies offer?
Stem Cell Technologies offers Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media.
How many acquisitions has Stem Cell Technologies made?
Stem Cell Technologies has made 3 acquisitions, including Cellular Highways, Propagenix, and SQZBiotech.
Who are Stem Cell Technologies's investors?
Stem Cell Technologies has 3 investors. Key investors include National Research Council Canada, European Union, and BDC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.